aHUS
Rare disease · 2017–2017
1decision
1medicine
1carried consumer input
226individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| eculizumab Treatment of patients with atypical haemolytic uraemic syndrome (aHUS) in end stage renal disease (ESRD) on chronic dialysis who are suitable for renal… | Jul 2017 | Recommended with restriction | 226 individuals |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.